Merck: A Tale of Two Global Giants

Discover the century-long split between the two Mercks, from a 1600s German pharmacy to the massive pharmaceutical rivals they are today.[INTRO]ALEX: If you go into a pharmacy today, you’ll see the name Merck everywhere. But if you’re in Germany, that name belongs to the oldest pharmaceutical company in the world. If you’re in New Jersey, it belongs to a completely different company that was actually seized as 'enemy property' during World War I.JORDAN: Wait, so there are two different Mercks? Are they like distant cousins who don’t talk anymore?ALEX: It’s more like a forced divorce. One family, two world-spanning giants, and a 100-year-old legal battle over who gets to use the name on the front door. We're talking about a story that spans from a 17th-century 'Angel Pharmacy' to a $25 billion cancer drug.[CHAPTER 1 - Origin]ALEX: To find the root, we have to go back to 1668 in Darmstadt, Germany. Friedrich Jacob Merck buys the 'Engel-Apotheke,' or Angel Pharmacy. For nearly two hundred years, it stays a local family business.JORDAN: So how does a local pharmacy become a global drug lord?ALEX: It starts in 1827. Heinrich Emanuel Merck stops just selling herbs and starts manufacturing alkaloids on an industrial scale. Think morphine and cocaine. Suddenly, they aren't just a shop; they are a factory. By 1891, the founder's grandson, George Merck, decides they need a piece of the American dream. He moves to New York and sets up a subsidiary: Merck & Co.JORDAN: So, at this point, they’re still one big happy family? One German parent, one American child?ALEX: Exactly. For twenty years, the American branch just imports and sells German chemicals. The world was globalizing. But then, 1917 happens. The U.S. enters World War I against Germany.JORDAN: And I’m guessing being a German company in America during the Great War was... not great for business?ALEX: It was terminal. Under the Trading with the Enemy Act, the U.S. government literally seized Merck & Co. They treated it as enemy property. George Merck eventually had to buy his own company back from the American government just to stay in business. That was the 'Great Schism.' The silver cord was cut forever.[CHAPTER 2 - Core Story]ALEX: Now, the American Merck had to figure out how to be more than just a middleman for their former German parents. George W. Merck, the founder’s son, takes over and makes a bold claim. He says, 'Medicine is for the people... not for the profits.'JORDAN: Sounds noble, but did he actually follow through? Or was that just early PR?ALEX: Actually, he walked the walk. In 1933, he built the Merck Research Laboratories. They became the first to mass-produce Vitamin C. During World War II, they worked with the government to figure out how to mass-produce penicillin, which saved millions of lives on the front lines. They even helped discover the first effective treatment for tuberculosis.JORDAN: So they became the heroes of the pharmaceutical world. But I know this industry—there’s always a dark side. ALEX: There’s a massive one. For decades, Merck was the gold standard. In 1987, they even gave away a drug called Mectizan for free to cure river blindness in Africa. They still do it today. But then came the year 2004, and the name of the disaster was Vioxx.JORDAN: Vioxx... I remember those commercials. It was a painkiller, right?ALEX: A blockbuster painkiller. It was making $2.5 billion a year. But a study found it significantly increased the risk of heart attacks and strokes. Merck had to pull it from the shelves overnight. They faced over 27,000 lawsuits.JORDAN: 27,000? That’s not a lawsuit, that’s an army. Did they know it was dangerous before they sold it?ALEX: That was the trillion-dollar question. Internal documents suggested they had seen safety red flags years earlier. It cost them nearly $6 billion in settlements and destroyed their reputation as the 'ethical' pharma company. They went from the savior of the world to the poster child for corporate greed in a single afternoon.JORDAN: So how did they recover? Or are they just a shell of their former selves?ALEX: They did what big pharma does: they merged. In 2009, they bought Schering-Plough for $41 billion to stay afloat. And then, they hit the jackpot again with a drug called Keytruda.JORDAN: Keytruda. That’s the cancer immunotherapy everyone talks about now, right?ALEX: It’s the engine of the entire company. In 2023 alone, that one drug brought in $25 billion. It’s transformed how we treat cancer, but it also created a new problem. Merck is now so dependent on Keytruda that they’re facing a 'patent cliff' in 2028. When that patent expires, anyone can make a generic version.[CHAPTER 3 - Why It Matters]JORDAN: So, they’re basically in a race against time now. But why should we care about this specific company versus any other giant drug maker?ALEX: Because the Merck story is the story of the modern world. It shows how war can split a family legacy in two. It shows the incredible power of research to cure diseases that have plagued humans for centuries, like river blindness or TB. But it also shows the danger of the 'blockbuster' model—where a company becomes so reliant on one drug that they might ignore the risks to keep the profit coming.JORDAN: It’s wild that because of a 100-year-old war, there are still two Mercks today. If I’m in London and I see a Merck sign, which one is it?ALEX: If you’re outside North America, the American company has to call itself 'MSD'—Merck Sharp & Dohme. Only the original German company gets to be called 'Merck' everywhere else. They’ve spent a century in courtrooms just fighting over the five letters in their name.[OUTRO]JORDAN: What’s the one thing to remember about this?ALEX: Merck is a 350-year-old legacy that proves while science can save the world, the business of medicine is often a battlefield of ethics, accidents, and international law.JORDAN: That’s Wikipodia — every story, on demand. Search your next topic at wikipodia.ai.